Sharrp Ventures leads 100 CR investment in Naturis Cosmetics’ first institutional funding round

▴ Rahul Tandon, CEO of Naturis Cosmetics
The new influx of capital will enable manufacturing expansion and R&D capabilities.

India-wide release, 16 July 2026: India’s leading CDMO player in the fast-growing beauty & personal care (BPC) sector, Naturis Cosmetics, has raised INR 100 crore in its first external funding round. The investment was led by Sharrp Ventures, with participation from Mirabilis Investment Trust (Infosys Co-founder K. Dinesh Family Office), financial growth equity investors Anicut Capital and Niveshaay, D2C ecosystem leaders including Suyash Saraf (Hyperscale Ventures) and Yogesh Kabra, along with several prominent angel investors from pharma and specialty chemical ecosystems. 

Naturis Cosmetics is an R&D-led manufacturing company with a track record of enabling 50+ category-winning D2C and leading BPC brands in India, including Pilgrim, Purplle, Nykaa, Asaya, Hoop, Colorbar, Innovist’s Bare Anatomy, Kay Beauty, and Antinorm, amongst others. The Mumbai-based company also partners with several pharmaceutical companies like Glenmark and Dr. Reddy’s Laboratories for new-age OTC and cosmeceuticals backed by unique technologies. 

The fresh capital will enable Naturis Cosmetics to accelerate its vision of leading the next decade of innovation and growth in the BPC sector. It aims to become the platform of choice for beauty, personal care, and wellness brands across D2C, FMCG, and OTC pharma. The company also plans to expand its geographical presence across the country by establishing a new state-of-the-art production unit in Vapi, spanning 225,000 sq. ft, an experience centre in the NCR region, and a new R&D centre in Mumbai. Additionally, it will significantly scale its team across verticals. 

Over the next five years, Naturis intends to diversify into high-growth categories, including men’s grooming, body care, colour cosmetics, fragrances, and exports, while strengthening its capabilities in OTC pharma. The company also plans to deepen its innovation funnels with both existing and new brands. 

Commenting on the funds raised, Rahul Tandon, Co-Founder & CEO of Naturis Cosmetics, said, “Our long-term vision is to build India’s leading ODM platform in the BPC space. This investment is not just a vote of confidence in Naturis, but also in India’s manufacturing and innovation ecosystem. With the strategic expertise of our investors and partners, we are well-positioned to accelerate our growth, strengthen our R&D capabilities, expand our manufacturing footprint, and help build the next generation of brands from India. We are grateful for the trust our investors have placed in us and remain committed to building the backbone of the industry through innovation, agility, and integrity.”

Divya Gupta, Principal at Sharrp Ventures, added, “What stood out to us about Naturis was its ability to combine deep formulation and product development capability with strong quality systems and a customer-first way of working. Its customers see Naturis not just as a supplier, but as a partner of choice, which has enabled the company to scale rapidly while delivering strong financial performance. As Naturis grows, we believe it has the potential to become a trusted product innovation and manufacturing platform for domestic and global brands. We are happy to partner with the team in its journey of building an enduring institution.”

Furthermore, Mr. Sagar Kandhari, Partner at Ambassador Capital Partners, advised Naturis Cosmetics through its fundraising process and has joined the company’s Board to support its next phase of strategic growth and scale-up.

India’s beauty and personal care industry is entering a period of unprecedented growth. As per a recent Redseer Report, the country will be the fourth-largest beauty and personal care (BPC) market globally, growing to $40 billion by 2030. This is driven by rising consumer awareness, higher disposable incomes, and easy accessibility. Consequently, the demand for innovation-led manufacturing partners is also growing significantly. 

A profitable company with a revenue growth of 50%+ CAGR over the last four years, Naturis Cosmetics is well-positioned to lead this next phase of growth. The move marks a significant milestone not just for the company, but for India’s rapidly evolving beauty and personal care manufacturing ecosystem. Bringing together institutional investors, family offices, and experienced operators from the D2C and healthcare sectors, this first-of-its-kind investment reflects growing confidence in the manufacturing infrastructure, building a robust backbone of India’s BPC sector.

Tags : #

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026